Alector is a pioneering brand with a clear mission: to erase neurodegenerative diseases and restore the experience of life for patients, caregivers, and families. Combining immunology, neuroscience, and human genetics, Alector is at the forefront of immuno-neurology, a groundbreaking therapeutic approach to halt neurodegeneration. With relentless curiosity and a determination to make a difference, Alector is building an ambitious pipeline of unique therapeutic candidates that harness the body's immune system to revolutionize the treatment of brain diseases and beyond.

By focusing on devastating conditions such as frontotemporal dementia, Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, and more, Alector aims to profoundly impact humanity. Led by experienced leaders in biotechnology and pharmaceutical industries, Alector is driven by a shared passion to transform the course of neurodegenerative diseases. Join Alector on their mission to unlock the impossible and improve the lives of patients worldwide